RTI Surgical® Announces 2015 Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- S&P 500, Nasdaq futures slip after tech rally; Warsh's speech awaited
- Oil holds steady, on track for weekly fall on US-Iran talks stalemate
- Dollar heads for weekly gain as Warsh remarks awaited
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Ovintiv adds 41,000 acres in Permian and Montney deals
- Russia says it could strike UK military targets in response to Kyiv's use of British missiles
Canaccord Genuity Downgrades RTI Biologics (RTIX) to Hold
October 30, 2015 8:07 AM EDTCanaccord Genuity downgraded RTI Biologics (NASDAQ: RTIX) from Buy to Hold with a price target of $4.00.
For an analyst ratings summary and ratings history on RTI Biologics click here. For more ratings news on RTI Biologics click here.
Shares of RTI Biologics closed at $4.40 yesterday.
... MoreRTI Surgical (RTIX) Reports In-Line Q3 EPS; Trims FY15 Outlook
October 29, 2015 9:09 AM EDTRTI Surgical (NASDAQ: RTIX) reported Q3 EPS of $0.05, in-line with the analyst estimate of $0.05. Revenue for the quarter came in at $66.5 million versus the consensus estimate of $69.53 million.
RTI Surgical sees FY2015 EPS of $0.19, versus prior guidance of $0.20-$0.23 and the consensus of... More
